A novel heart failure mice model of hypertensive heart disease by angiotensin II infusion, nephrectomy, and salt loading

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 305, Issue 11, 2013, Pages

  Tsukamoto, Yasumasa ^a,b   Mano, Toshiaki ^a,b   Sakata, Yasushi ^a   Ohtani, Tomohito ^a   Takeda, Yasuharu ^a   Tamaki, Shunsuke ^a,b   Omori, Yosuke ^a,b   Ikeya, Yukitoshi ^a,c   Saito, Yuki ^a,c   Ishii, Ryohei ^d   Higashimori, Mitsuru ^d   Kaneko, Makoto ^d   Miwa, Takeshi ^b   Yamamoto, Kazuhiro ^e   Komuro, Issei ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d OSAKA UNIVERSITY   (Japan)

^e TOTTORI UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Heart failure; Hypertensive heart disease; Mouse model; Renal dysfunction; Salt loading

Indexed keywords

ANGIOTENSIN II; GUANOSINE TRIPHOSPHATASE; RAC1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG INFUSION; ENZYME ACTIVITY; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HYPERTENSION; INCIDENCE; LUNG WEIGHT; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; SALT LOADING; SYSTOLIC BLOOD PRESSURE; UNINEPHRECTOMY; UPREGULATION;

ANGIOTENSIN II; HEART FAILURE; HYPERTENSIVE HEART DISEASE; MOUSE MODEL; RENAL DYSFUNCTION; SALT LOADING;

ANGIOTENSIN II; ANIMALS; ANIMALS, NEWBORN; BLOOD PRESSURE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FIBROSIS; GENE EXPRESSION REGULATION; HEART FAILURE; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MICE; MICE, INBRED C57BL; MYOCARDIUM; NEPHRECTOMY; NEUROPEPTIDES; OXIDATIVE STRESS; PULMONARY EDEMA; RAC1 GTP-BINDING PROTEIN; RATS; RATS, WISTAR; SODIUM CHLORIDE, DIETARY; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 84888872239     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00349.2013     Document Type: Article

References (53)

1. Belch JJ, Bridges AB, Scott N, Chopra M. Oxygen free radicals and congestive heart failure. Br Heart J 65: 245-248, 1991.
2. Carlstrom M, Sallstrom J, Skott O, Larsson E, Persson AE. Uninephrectomy in young age or chronic salt loading causes salt-sensitive hypertension in adult rats. Hypertension 49: 1342-1350, 2007.
3. Custodis F, Eberl M, Kilter H, Böhm M, Laufs U. Association of RhoGDIα with Rac1 GTPase mediates free radical production during myocardial hypertrophy. Cardiovasc Res 71: 342-351, 2006.
4. Doi R, Masuyama T, Yamamoto K, Doi Y, Mano T, Sakata Y, Ono K, Kuzuya T, Hirota S, Koyama T, Miwa T, Hori M. Development of different phenotypes of hypertensive heart failure: systolic versus diastolic failure in Dahl salt-sensitive rats. J Hypertens 18: 111-120, 2000.
5. -/- mice with cardiac hypertrophy and fibrosis. Am J Physiol Heart Circ Physiol 283: H707-H714, 2002.
6. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004.
7. Graudal NA, Galløe AM, Garred P. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: a meta-analysis. JAMA 279: 1383-1391, 1998.
8. Grieve DJ, Shah AM. Oxidative stress in heart failure. More than just damage. Eur Heart J 24: 2161-2163, 2003.
9. Gu JW, Anand V, Shek EW, Moore MC, Brady AL, Kelly WC, Adair TH. Sodium induces hypertrophy of cultured myocardial myoblasts and vascular smooth muscle cells. Hypertension 31: 1083-1087, 1998.
10. Harding P, Yang XP, He Q, Lapointe MC. Lack of microsomal prostaglandin E synthase-1 reduces cardiac function following angiotensin II infusion. Am J Physiol Heart Circ Physiol 300: H1053-H1061, 2011.
11. Hart CY, Meyer DM, Tazelaar HD, Grande JP, Burnett JC, Housmans PR, Redfield MM. Load versus humoral activation in the genesis of early hypertensive heart disease. Circulation 104: 215-220, 2001.
12. Haudek SB, Cheng J, Du J, Wang Y, Hermosillo-Rodriguez J, Trial J, Taffet GE, Entman ML. Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy. J Mol Cell Cardiol 49: 499-507, 2010.
13. Hikoso S, Yamaguchi O, Nakano Y, Takeda T, Omiya S, Mizote I, Taneike M, Oka T, Tamai T, Oyabu J, Uno Y, Matsumura Y, Nishida K, Suzuki K, Kogo M, Hori M, Otsu K. The IκB kinase β/nuclear factor κB signaling pathway protects the heart from hemodynamic stress mediated by the regulation of manganese superoxide dismutase expression. Circ Res 105: 70-79, 2009.
14. Hill MF, Singal PK. Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol 148: 291-300, 1996.
15. Houser SR, Margulies KB, Murphy AM, Spinale FG, Francis GS, Prabhu SD, Rockman HA, Kass DA, Molkentin JD, Sussman MA, Koch WJ, Koch W; American Heart Association Council on Basic Cardiovascular Sciences, Council on Clinical Cardiology, Council on Functional Genomics and Translational Biology. Animal models of heart failure: a scientific statement from the American Heart Association. Circ Res 111: 131-150, 2012.
16. Huang WC, Levey AS, Serio AM, Snyder M, Vickers AJ, Raj GV, Scardino PT, Russo P. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 7: 735-740, 2006.
17. Ishii R, Higashimori M, Tadakuma K, Kaneko M, Tamaki S, Sakata Y, Yamamoto K. Balloon type elasticity sensing for left ventricle of small laboratory animal. Conf Proc IEEE Eng Med Biol Soc 2011: 904-907, 2011.
18. Ito S, Nagasawa T, Abe M, Mori T. Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk. Hypertens Res 32: 115-121, 2009.
19. 2 receptors. J Clin Invest 116: 1302-1309, 2006.
20. Kennedy DJ, Elkareh J, Shidyak A, Shapiro AP, Smaili S, Mutgi K, Gupta S, Tian J, Morgan E, Khouri S, Cooper CJ, Periyasamy SM, Xie Z, Malhotra D, Fedorova OV, Bagrov AY, Shapiro JI. Partial nephrectomy as a model for uremic cardiomyopathy in the mouse. Am J Physiol Renal Physiol 294: F450-F454, 2008.
21. Keppler A, Gretz N, Schmidt R, Kloetzer HM, Groene HJ, Lelongt B, Meyer M, Sadick M, Pill J. Plasma creatinine determination in mice and rats: an enzymatic method compares favorably with a high-performance liquid chromatography assay. Kidney Int 71: 74-78, 2007.
22. Kopkan L, Cervenka L. Renal interactions of renin-angiotensin system, nitric oxide and superoxide anion: implications in the pathophysiology of salt-sensitivity and hypertension. Physiol Res 58, Suppl 2: S55-S67, 2009.
23. Leelahavanichkul A, Yan Q, Hu X, Eisner C, Huang Y, Chen R, Mizel D, Zhou H, Wright EC, Kopp JB, Schnermann J, Yuen PS, Star RA. Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model. Kidney Int 78: 1136-1153, 2010.
24. Li Y, Takemura G, Okada H, Miyata S, Maruyama R, Esaki M, Kanamori H, Li L, Ogino A, Ohno T, Kondo T, Nakagawa M, Minatoguchi S, Fujiwara T, Fujiwara H. Molecular signaling mediated by angiotensin II type 1A receptor blockade leading to attenuation of renal dysfunction-associated heart failure. J Card Fail 13: 155-162, 2007.
25. Liao CH, Akazawa H, Tamagawa M, Ito K, Yasuda N, Kudo Y, Yamamoto R, Ozasa Y, Fujimoto M, Wang P, Nakauchi H, Nakaya H, Komuro I. Cardiac mast cells cause atrial fibrillation through PDGF-Amediated fibrosis in pressure-overloaded mouse hearts. J Clin Invest 120: 242-253, 2010.
26. Liao Y, Ishikura F, Beppu S, Asakura M, Takashima S, Asanuma H, Sanada S, Kim J, Ogita H, Kuzuya T, Node K, Kitakaze M, Hori M. Echocardiographic assessment of LV hypertrophy and function in aorticbanded mice: necropsy validation. Am J Physiol Heart Circ Physiol 282: H1703-H1708, 2002.
27. Luque M, de Rivas B, Divison JA, Marquez E, Sobreviela E. Relationship between renal function and heart failure in hypertensive patients. Intern Med J 40: 76-79, 2010.
28. Mohammed SF, Storlie JR, Oehler EA, Bowen LA, Korinek J, Lam CS, Simari RD, Burnett JC Jr, Redfield MM. Variable phenotype in murine transverse aortic constriction. Cardiovasc Pathol 21: 188-198, 2012.
29. Ohtani T, Mano T, Hikoso S, Sakata Y, Nishio M, Takeda Y, Otsu K, Miwa T, Masuyama T, Hori M, Yamamoto K. Cardiac steroidogenesis and glucocorticoid in the development of cardiac hypertrophy during the progression to heart failure. J Hypertens 27: 1074-1083, 2009.
30. Ohtani T, Ohta M, Yamamoto K, Mano T, Sakata Y, Nishio M, Takeda Y, Yoshida J, Miwa T, Okamoto M, Masuyama T, Nonaka Y, Hori M. Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: beneficial effects of mineralocorticoid receptor blocker. Am J Physiol Regul Integr Comp Physiol 292: R946-R954, 2007.
31. Oka T, Maillet M, Watt AJ, Schwartz RJ, Aronow BJ, Duncan SA, Molkentin JD. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ Res 98: 837-845, 2006.
32. Omiya S, Hikoso S, Imanishi Y, Saito A, Yamaguchi O, Takeda T, Mizote I, Oka T, Taneike M, Nakano Y, Matsumura Y, Nishida K, Sawa Y, Hori M, Otsu K. Downregulation of ferritin heavy chain increases labile iron pool, oxidative stress and cell death in cardiomyocytes. J Mol Cell Cardiol 46: 59-66, 2009.
33. Omori Y, Ohtani T, Sakata Y, Mano T, Takeda Y, Tamaki S, Tsukamoto Y, Kamimura D, Aizawa Y, Miwa T, Komuro I, Soga T, Yamamoto K. L-Carnitine prevents the development of ventricular fibrosis and heart failure with preserved ejection fraction in hypertensive heart disease. J Hypertens 30: 1834-1844, 2012.
34. Pacher P, Nagayama T, Mukhopadhyay P, Bátkai S, Kass DA. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc 3: 1422-1434, 2008.
35. Patten RD, Hall-Porter MR. Small animal models of heart failure: development of novel therapies, past and present. Circ Heart Fail 2: 138-144, 2009.
36. Pfeffer JM, Pfeffer MA, Mirsky I, Braunwald E. Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat. Proc Natl Acad Sci USA 79: 3310-3314, 1982.
37. Querejeta R, Lopez B, Gonzalez A, Sanchez E, Larman M, Martinez Ubago JL, Diez J. Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis. Circulation 110: 1263-1268, 2004.
38. Rodriguez-Gomez I, Wangensteen R, Perez-Abud R, Quesada A, Del Moral RG, Osuna A, O'Valle F, de Dios Luna J, Vargas F. Long-term consequences of uninephrectomy in male and female rats. Hypertension 60: 1458-1463, 2012.
39. Sakata Y, Yamamoto K, Masuyama T, Mano T, Nishikawa N, Kuzuya T, Miwa T, Hori M. Ventricular production of natriuretic peptides and ventricular structural remodeling in hypertensive heart failure. J Hypertens 19: 1905-1912, 2001.
40. Segura AM, Frazier OH, Buja LM. Fibrosis and heart failure. Heart Fail Rev. In press.
41. Shen E, Li Y, Shan L, Zhu H, Feng Q, Arnold JM, Peng T. Rac1 is required for cardiomyocyte apoptosis during hyperglycemia. Diabetes 58: 2386-2395, 2009.
42. Shibata S, Mu S, Kawarazaki H, Muraoka K, Ishizawa K, Yoshida S, Kawarazaki W, Takeuchi M, Ayuzawa N, Miyoshi J, Takai Y, Ishikawa A, Shimosawa T, Ando K, Nagase M, Fujita T. Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway. J Clin Invest 121: 3233-3243, 2011.
43. Siri FM, Nordin C, Factor SM, Sonnenblick E, Aronson R. Compensatory hypertrophy and failure in gradual pressure-overloaded guinea pig heart. Am J Physiol Heart Circ Physiol 257: H1016-H1024, 1989.
44. Strazzullo P, D'Elia L, Kandala NB, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ 339: b4567, 2009.
45. Tamaki S, Mano T, Sakata Y, Ohtani T, Takeda Y, Kamimura D, Omori Y, Tsukamoto Y, Ikeya Y, Kawai M, Kumanogoh A, Hagihara K, Ishii R, Higashimori M, Kaneko M, Hasuwa H, Miwa T, Yamamoto K, Komuro I. Interleukin-16 promotes cardiac fibrosis and myocardial stiffening in heart failure with preserved ejection fraction. PLos One 8: e68893, 2013.
46. Terui T, Shimamoto Y, Yamane M, Kobirumaki F, Ohtsuki I, Ishiwata S, Kurihara S, Fukuda N. Regulatory mechanism of lengthdependent activation in skinned porcine ventricular muscle: role of thin filament cooperative activation in the Frank-Starling relation. J Gen Physiol 136: 469-482, 2010.
47. Torricelli FC, Danilovic A, Marchini GS, Sant'Anna AC, Dall'Oglio MF, Srougi M. Can we predict which patients will evolve to chronic kidney disease after nephrectomy for cortical renal tumors? Int Braz J Urol 38: 637-644, 2012.
48. Tsutsui H, Kinugawa S, Matsushima S. Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol 301: H2181-H2190, 2011.
49. Xu Z, Okamoto H, Akino M, Onozuka H, Matsui Y, Tsutsui H. Pravastatin attenuates left ventricular remodeling and diastolic dysfunction in angiotensin II-induced hypertensive mice. J Cardiovasc Pharmacol 51: 62-70, 2008.
50. 1 receptor downregulation and 'overdrive' of the endothelin system. Cardiovasc Res 46: 421-432, 2000.
51. Yamamoto K, Masuyama T, Sakata Y, Nishikawa N, Mano T, Yoshida J, Miwa T, Sugawara M, Yamaguchi Y, Ookawara T, Suzuki K, Hori M. Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart. Cardiovasc Res 55: 76-82, 2002.
52. Yoshida M, Shiojima I, Ikeda H, Komuro I. Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity. J Mol Cell Cardiol 47: 698-705, 2009.
53. Zhang R, Zhang YY, Huang XR, Wu Y, Chung AC, Wu EX, Szalai AJ, Wong BC, Lau CP, Lan HY. C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease. Hypertension 55: 953-960, 2010.